Health
NHS England spends £160m on new ‘Covid-friendly’ cancer drugs – The Guardian
Patients to be given treatments less likely to damage immune system and in some cases able to be taken at home
NHS England is spending £160m on new Covid-friendly cancer drugs that will be less likely to damage the immune system and, in some cases, can be taken at home so that patients do not have to visit hospital.
NHS England said 2,000 patients had already benefitted from a range of treatments approved for use as swaps for existing drugs. More will be available from this week, after a series of deals struck between the NHS and pharma companies, it said in a statement.
Some of these new options mean …
-
Business17 hours ago3 ASX 200 blue chip shares to buy with $3,000 in July
-
Noosa News20 hours agoMan stabbed at luxury home identified as police theory emerges
-
Noosa News19 hours agoCommissioner’s 100-Day Review of the Queensland Police Service – Final Report
-
General12 hours agoChina hails PM’s ‘personal efforts’ to restore ties